AC
Applied Clinical Trials
ACT Brief: Community Research Financing Gaps, Neuroscience Endpoint Data, and Teva’s Biosimilar Deal
0:00-1:57
In today’s ACT Brief, we examine why community research needs lasting financing and infrastructure, how electronic outcome tools can strengthen neuroscience endpoints, and how Teva is licensing two biosimilars from Samsung Bioepis.
Publisher
Applied Clinical Trials
Link
audioboom.com/posts/8972833
Published
November 4, 2026
Duration
2 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
AC
Applied Clinical Trials
@appliedclinicaltrials
#communityresearchfinancing #neuroscienceendpointdata #tevasbiosimilardeal #lifesciences
